Compounds > oxazoles
Page last updated: 2024-08-21

oxazoles and cyc 202

oxazoles has been researched along with cyc 202 in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (66.67)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brahmi, Z; N'cho, M1
Cress, WD; Freeman, SN; Ma, Y1
Blagden, S; de Bono, J1
Chen, R; Chubb, S; Fox, JA; Gandhi, V; Hawtin, RE; Keating, MJ; Plunkett, W; Wierda, WG1
Huttunen, HJ; Kysenius, K; Nykänen, NP; Sakha, P; Tammela, P1
Giordano, A; Morales, F1

Reviews

2 review(s) available for oxazoles and cyc 202

ArticleYear
Drugging cell cycle kinases in cancer therapy.
    Current drug targets, 2005, Volume: 6, Issue:3

    Topics: Adenosine Triphosphate; Animals; Antineoplastic Agents; Binding Sites; Cyclin-Dependent Kinases; Flavonoids; Humans; Neoplasms; Oxazoles; Piperidines; Protein Kinase Inhibitors; Purines; Roscovitine; Staurosporine; Sulfonamides; Thiazoles

2005
Overview of CDK9 as a target in cancer research.
    Cell cycle (Georgetown, Tex.), 2016, Volume: 15, Issue:4

    Topics: Bridged Bicyclo Compounds, Heterocyclic; Cell Cycle; Cyclic N-Oxides; Cyclin-Dependent Kinase 9; Flavonoids; Humans; Indolizines; Molecular Targeted Therapy; Neoplasms; Oxazoles; Piperidines; Protein Kinase Inhibitors; Purines; Pyrazoles; Pyridinium Compounds; Roscovitine; Thiazoles; Urea

2016

Other Studies

4 other study(ies) available for oxazoles and cyc 202

ArticleYear
Evidence that Fas-induced apoptosis leads to S phase arrest.
    Human immunology, 2001, Volume: 62, Issue:4

    Topics: Apoptosis; CDC2-CDC28 Kinases; Cell Cycle; Cell Division; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinases; DNA Fragmentation; Enzyme Inhibitors; fas Receptor; Humans; Jurkat Cells; Marine Toxins; Oxazoles; Phosphoprotein Phosphatases; Poly(ADP-ribose) Polymerases; Protein Serine-Threonine Kinases; Purines; Roscovitine; S Phase

2001
E2F4 deficiency promotes drug-induced apoptosis.
    Cancer biology & therapy, 2004, Volume: 3, Issue:12

    Topics: Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Cell Cycle Proteins; DNA-Binding Proteins; E2F Transcription Factors; E2F1 Transcription Factor; E2F4 Transcription Factor; Fibroblasts; Flavonoids; Humans; Lung Neoplasms; Mice; Mice, Knockout; Oxazoles; Piperidines; Protein Kinase Inhibitors; Purines; RNA, Small Interfering; Roscovitine; Thiazoles; Transcription Factors; Tumor Cells, Cultured

2004
Mechanism of action of SNS-032, a novel cyclin-dependent kinase inhibitor, in chronic lymphocytic leukemia.
    Blood, 2009, May-07, Volume: 113, Issue:19

    Topics: Adult; Aged; Aged, 80 and over; Apoptosis; Caspases; Cyclin-Dependent Kinases; Female; Flavonoids; Humans; Immunoblotting; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphocytes; Male; Membrane Potential, Mitochondrial; Middle Aged; Myeloid Cell Leukemia Sequence 1 Protein; Oxazoles; Phosphorylation; Piperidines; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-bcl-2; Purines; RNA Polymerase II; RNA, Neoplasm; Roscovitine; Thiazoles; Transcription, Genetic; X-Linked Inhibitor of Apoptosis Protein

2009
γ-Aminobutyric acid type A (GABAA) receptor activation modulates tau phosphorylation.
    The Journal of biological chemistry, 2012, Feb-24, Volume: 287, Issue:9

    Topics: Alzheimer Disease; Animals; Cell Line, Tumor; Cyclin-Dependent Kinase 5; Cytoskeleton; Enzyme Inhibitors; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Marine Toxins; Mice; Naphthoquinones; Nerve Degeneration; Neuroblastoma; NIMA-Interacting Peptidylprolyl Isomerase; Oxazoles; Peptidylprolyl Isomerase; Phosphorylation; Protein Kinase Inhibitors; Protein Phosphatase 2; Purines; Rats; Receptors, GABA-A; Roscovitine; tau Proteins; Tauopathies

2012